Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis

Tff2定义了缺乏再生潜能且能抵抗Kras驱动的癌变的胰腺腺泡祖细胞,这些祖细胞具有增殖能力。

阅读:8
作者:Zhengyu Jiang ,Feijing Wu ,Pasquale Laise ,Tanaka Takayuki ,Fu Na ,Woosook Kim ,Hiroki Kobayashi ,Wenju Chang ,Ryota Takahashi ,Giovanni Valenti ,Masaki Sunagawa ,Ruth A White ,Marina Macchini ,Bernhard W Renz ,Moritz Middelhoff ,Yoku Hayakawa ,Zinaida A Dubeykovskaya ,Xiangtian Tan ,Timothy H Chu ,Karan Nagar ,Yagnesh Tailor ,Bryana R Belin ,Akanksha Anand ,Samuel Asfaha ,Michael O Finlayson ,Alina C Iuga ,Andrea Califano ,Timothy C Wang

Abstract

While adult pancreatic stem cells are thought not to exist, it is now appreciated that the acinar compartment harbors progenitors, including tissue-repairing facultative progenitors (FPs). Here, we study a pancreatic acinar population marked by trefoil factor 2 (Tff2) expression. Long-term lineage tracing and single-cell RNA sequencing (scRNA-seq) analysis of Tff2-DTR-CreERT2-targeted cells defines a transit-amplifying progenitor (TAP) population that contributes to normal homeostasis. Following acute and chronic injury, Tff2+ cells, distinct from FPs, undergo depopulation but are eventually replenished. At baseline, oncogenic KrasG12D-targeted Tff2+ cells are resistant to PDAC initiation. However, KrasG12D activation in Tff2+ cells leads to survival and clonal expansion following pancreatitis and a cancer stem/progenitor cell-like state. Selective ablation of Tff2+ cells prior to KrasG12D activation in Mist1+ acinar or Dclk1+ FP cells results in enhanced tumorigenesis, which can be partially rescued by adenoviral Tff2 treatment. Together, Tff2 defines a pancreatic TAP population that protects against Kras-driven carcinogenesis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。